The Effect of Adding Metformin to the Treatment of Hepatitis C
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Insulin resistance is known to adversely effect viral response to treatment in hepatitis C
patients
We are aiming to study the effect of an insulin sensitizer, metformin, in viral response of
hepatitis C to treatment with pegylated interferon and ribavirin in a double blind randomized
controlled trial